Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -114.31%-1.37M | ---- | -58.56%9.6M | ---- | 67.33%23.15M | ---- | -56.33%13.84M | ---- | 3.53%31.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.39%-2.54M | ---- | -165.06%-2.53M | ---- | -568.53%-956K | ---- | 76.75%-143K | ---- | 43.42%-615K |
| Interest expense - adjustment | ---- | -9.85%293K | ---- | 151.94%325K | ---- | -53.93%129K | ---- | 1.08%280K | ---- | 42.78%277K |
| Impairment and provisions: | ---- | 11.21%1.16M | ---- | 131.62%1.04M | ---- | -165.13%-3.3M | ---- | 353.49%5.07M | ---- | -25.96%1.12M |
| -Impairment of trade receivables (reversal) | ---- | 11.21%1.16M | ---- | 133.76%1.04M | ---- | -160.99%-3.09M | ---- | 353.49%5.07M | ---- | -25.96%1.12M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---210K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -31.98%5.12M | ---- | -21.38%7.53M | ---- | -0.92%9.58M | ---- | 48.88%9.67M | ---- | -21.52%6.49M |
| -Depreciation | ---- | -80.74%597K | ---- | -41.90%3.1M | ---- | -1.62%5.33M | ---- | 146.79%5.42M | ---- | -43.77%2.2M |
| Special items | ---- | ---- | ---- | -784.29%-1.24M | ---- | ---140K | ---- | ---- | ---- | ---5.22M |
| Operating profit before the change of operating capital | ---- | -81.94%2.66M | ---- | -48.27%14.72M | ---- | -0.87%28.46M | ---- | -14.88%28.71M | ---- | -14.59%33.73M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 182.66%4.17M | ---- | -434.59%-5.04M | ---- | 137.95%1.51M | ---- | -466.39%-3.97M | ---- | -75.42%1.08M |
| Accounts payable increase (decrease) | ---- | -294.36%-6.17M | ---- | 219.71%3.18M | ---- | 18.72%-2.65M | ---- | -414.02%-3.26M | ---- | 67.06%-635K |
| Special items for working capital changes | ---- | 743.28%1.13M | ---- | -66.50%134K | ---- | 105.26%400K | ---- | -242.39%-7.6M | ---- | -6.81%5.34M |
| Cash from business operations | ---- | -86.29%1.78M | ---- | -53.12%12.99M | ---- | 99.67%27.71M | ---- | -64.87%13.88M | ---- | -17.15%39.51M |
| Other taxs | ---- | -333.83%-3.19M | ---- | 64.36%-736K | ---- | -22.41%-2.07M | ---- | 51.54%-1.69M | ---- | 41.40%-3.48M |
| Special items of business | 34.89%4.64M | ---- | -64.98%3.44M | ---- | -54.97%9.81M | ---- | 64.84%21.8M | ---- | -49.56%13.22M | ---- |
| Net cash from operations | 34.89%4.64M | -111.52%-1.41M | -64.98%3.44M | -52.21%12.26M | -54.97%9.81M | 110.36%25.65M | 64.84%21.8M | -66.16%12.19M | -49.56%13.22M | -13.70%36.03M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 0.39%2.54M | ---- | 165.06%2.53M | ---- | 568.53%956K | ---- | -76.75%143K | ---- | -51.50%615K |
| Purchase of fixed assets | ---- | ---- | ---- | 54.46%-51K | ---- | 92.43%-112K | ---- | 86.21%-1.48M | ---- | -11,075.00%-10.73M |
| Other items in the investment business | -68.94%392K | ---- | 28.25%1.26M | ---- | 24,700.00%984K | ---- | 42.86%-4K | ---- | -102.27%-7K | ---- |
| Net cash from investment operations | -68.94%392K | 2.46%2.54M | 28.25%1.26M | 194.19%2.48M | 24,700.00%984K | 163.17%844K | 42.86%-4K | 86.79%-1.34M | -102.27%-7K | -962.88%-10.11M |
| Net cash before financing | 7.00%5.03M | -92.32%1.13M | -56.48%4.7M | -44.36%14.74M | -50.45%10.8M | 144.02%26.49M | 64.90%21.79M | -58.11%10.86M | -50.17%13.22M | -39.62%25.92M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | 9.85%-293K | ---- | -151.94%-325K | ---- | 53.93%-129K | ---- | -1.08%-280K | ---- | -42.78%-277K |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | 46.67%-32M | ---- | ---60M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | 55.97%-22.08M | ---- | -135,462.16%-50.16M | --5.22M |
| Net cash from financing operations | ---- | 1.61%-4.84M | ---- | 86.61%-4.92M | ---- | 43.15%-36.74M | 55.97%-22.08M | -4,855.92%-64.63M | -135,462.16%-50.16M | 102.49%1.36M |
| Net Cash | 7.00%5.03M | -137.78%-3.71M | -56.48%4.7M | 195.79%9.82M | 3,785.32%10.8M | 80.94%-10.25M | 99.21%-293K | -297.13%-53.78M | -239.50%-36.94M | 335.33%27.28M |
| Begining period cash | -4.74%74.58M | 14.34%78.29M | 14.34%78.29M | -13.02%68.47M | -13.02%68.47M | -40.59%78.72M | -40.59%78.72M | 25.93%132.49M | 25.93%132.49M | -9.92%105.21M |
| Cash at the end | -4.07%79.6M | -4.74%74.58M | 4.69%82.98M | 14.34%78.29M | 1.07%79.26M | -13.02%68.47M | -17.92%78.42M | -40.59%78.72M | -27.45%95.55M | 25.93%132.49M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --132.49M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --132.49M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.